Viracta Therapeutics, Inc. (VIRX) - Company Cash Volume

Corporate emblem and logo of Viracta Therapeutics (VIRX)

Viracta Therapeutics (VIRX) leads the therapy of EBV-related oncological diseases by utilizing a unique method of virus activation and destruction. Patent protection ensures global growth potential and high margins. The company's cash balance demonstrates current liquidity, with the indicator standing at 0.00. The business is currently developing a pipeline of targeted drugs through the clinical trial stage.

Viracta Therapeutics, Inc. - VIRX Company Cash Balance (period 07/04/2022 - 02/16/2025)

Financial and market metric breakdowns for Viracta Therapeutics (VIRX)

- current price and projected stock value:
- market capitalization indicators:
Analysis of all company metrics:VIRX Viracta Therapeutics
Brand item of Viracta

For an investor assessing an issuer's solvency, this indicator serves as a measure of liquidity. The metric aggregates the volume of available cash and equivalents, reflecting the company's ability to cover short-term obligations without seeking external financing. For Viracta Therapeutics (VIRX), the value of 0.00 is critical, as outsourcing production to CMOs requires a constant influx of capital. By analyzing current cash reserves, one can assess the business's margin of safety.

Direct competitors

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Cash Reserve TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Company Cash Volume|Fate Therapeutics, Inc. (FATE) - Company Liquid Assets|Company Cash on Hand WHWK (Aadi Bioscience, Inc.)|Company Liquid Assets TScan Therapeutics, Inc.|Company Cash Volume CSBR (Champions Oncology Corp)|Company Total Cash Amount XBIT (XBiotech USA)|CVM - Company Cash Funds|Company Cash Balance OSTX (ostherapies.com)|Radiopharm Theranostics Ltd (RADX) - Company Cash Funds|ARTV: Company Total Cash Amount|ANL (adlainortye.com) - Company Cash Volume|VERU: Company Cash Balance|Company Cash on Hand TPST (Tempest Tx)|Company Cash on Hand Xilio XLO|Company Cash Volume RENB (Renovaro)|Company Cash Volume Mural Bio MURA|Kairos Pharma Ltd - Company Cash Volume|OnKure Therapeutics (OKUR) - Company Cash on Hand|GDTC: Company Cash Volume|Curis Inc. - Company Cash Balance|Company Cash Funds apollomicsinc.com|THAR: Company Cash Balance|Company Cash Funds Advanced Biomed Corp (ADVB)|GNPX (Genprex, Inc) - Company Cash Balance|Company Cash Volume CLDI (Calidi Biotherapeutics)|sunshinebiopharma.com (SBFM) - Company Cash Reserve|Xenetic Bio - Company Cash Volume|SLRX (Salarius Pharmaceuticals, Inc.) - Company Cash and Cash Equivalents|PPBT: Company Cash Volume|Company Cash on Hand American Oncology Network Inc|BGNE (beigene.com) - Company Cash Volume|Company Cash and Cash Equivalents CKPT (Checkpoint Therapeutics)|Company Cash on Hand ELEV (Elevation Oncology Inc.)|iCAD - Company Cash and Cash Equivalents|Ikena Oncology Inc. - Company Cash on Hand|Notable Labs Corp (NTBL) - Company Cash Reserve|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds